相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epiminocyclohepta[b]indole analogs as 5-HT6 antagonists
Alan J. Henderson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice
Virginie Da Silva Costa-Aze et al.
PSYCHOPHARMACOLOGY (2012)
Rigidized 1-aryl sulfonyl tryptamines: Synthesis and pharmacological evaluation as 5-HT6 receptor ligands
Ramakrishna Nirogi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Serotonin Receptors of Type 6 (5-HT6): What can we Expect from them?
D. Marazziti et al.
CURRENT MEDICINAL CHEMISTRY (2011)
5-HT6 receptor and cognition
Xabier Codony et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: New series of highly potent and specific serotonin 5-HT6 receptor antagonists
Alexandre V. Ivachtchenko et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
Benny Bang-Andersen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Influence of social isolation in the rat on serotonergic function and memory - Relevance to models of schizophrenia and the role of 5-HT6 receptors
Charles A. Marsden et al.
NEUROPHARMACOLOGY (2011)
5-HT6 pharmacology inconsistencies
Franco Borsini et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
5-HT6 receptor ligands, EMD386088 and SB258585, differentially regulate 5-HT6 receptor-independent events
Hyung-Mun Yun et al.
TOXICOLOGY IN VITRO (2011)
The use of multi-target drugs in the treatment of neurodegenerative diseases
Cornelis J Van der Schyf
Expert Review of Clinical Pharmacology (2011)
Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists
Alexandre V. Ivachtchenko et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Highly potent, non-basic 5-HT6 ligands. Site mutagenesis evidence for a second binding mode at 5-HT6 for antagonism
Ralph N. Harris et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
5-HT6 Receptor Antagonists as Potential Therapeutics for Cognitive Impairment
Gerard Rosse et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
The Medicinal Chemistry of 5-HT6 Receptor Ligands with a Focus on Arylsulfonyltryptamine Analogs
Richard A. Glennon et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
5-hydroxytryptamine subtype 6 receptor modulators: a patent survey
Alexandre V. Ivachtchenko et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Serotonin 6 receptor gene and mood disorders: Case-control study and meta-analysis
Yasuhisa Fukuo et al.
NEUROSCIENCE RESEARCH (2010)
Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data
Anna Wesolowska
PHARMACOLOGICAL REPORTS (2010)
5-HT6 Antagonists as Potential Treatment for Cognitive Dysfunction
Kevin G. Liu et al.
DRUG DEVELOPMENT RESEARCH (2009)
The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease
Werner J. Geldenhuys et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Pharmacological targeting of the serotonergic system for the treatment of obesity
Alastair S. Garfield et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Tricyclic azepine derivatives as selective brain penetrant 5-HT6 receptor antagonists
Giancarlo Trani et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Serotonin 5-HT6 receptor antagonists for the treatment of Alzheimer's disease
Werner J. Geldenhuys et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function
Kevin C. F. Fone
NEUROPHARMACOLOGY (2008)
5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease
Neil Upton et al.
NEUROTHERAPEUTICS (2008)
Selective 5-HT6 receptor ligands:: Progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders
D. J. Heal et al.
PHARMACOLOGY & THERAPEUTICS (2008)
A role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory
Madeleine V. King et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Neuropharmacological profile of novel and selective 5-HT6 receptor agonists:: WAY-181187 and WAY-208466
Lee E. Schechter et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Discovery of N1-(6-chloroimidazo[2,1-b][1,3]-thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT6 receptor agonist
Derek C. Cole et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Acute onset by 5-HT6-receptor activation on rat brain brain-derived neurotrophic factor and activity-regulated cytoskeletal-associated protein mRNA expression
G. De Foubert et al.
NEUROSCIENCE (2007)
Analysis of 5-HT6 and 5-HT7 receptor gene expression in rats showing differences in novelty-seeking behavior
S. J. Ballaz et al.
NEUROSCIENCE (2007)
Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation
Per Svenningsson et al.
JOURNAL OF NEUROSCIENCE (2007)
Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression
Anna Wesolowska et al.
NEUROPHARMACOLOGY (2007)
Serotonergic drugs - Effects on appetite expression and use for the treatment of obesity
Jason C. G. Halford et al.
DRUGS (2007)
Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats
Angels Fisas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models
Warren D. Hirst et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Lack of localization of 5-HT6 receptors on cholinergic neurons:: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release
Beatriz Marcos et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways
Gonzalo Romero et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Medicinal chemistry strategies to 5-HT6 receptor ligands as potential cognitive enhancers and antiobesity agents
J Holenz et al.
DRUG DISCOVERY TODAY (2006)
The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition
AG Ramage
BRITISH JOURNAL OF PHARMACOLOGY (2006)
5-HT6 receptors:: a novel target for cognitive enhancement
ES Mitchell et al.
PHARMACOLOGY & THERAPEUTICS (2005)
The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat
CKJ Lieben et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands
J Holenz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Influence of the 5-HT6 receptor on acetylcholine release in the cortex:: Pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist
C Riemer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons
VV Grigor'ev et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2003)
The distribution of 5-HT6 receptors in rat brain:: an autoradiographic binding study using the radiolabelled 5-HT6 receptor antagonist [125I]SB-258585
JC Roberts et al.
BRAIN RESEARCH (2002)
The 5-HT6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus
LA Dawson et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Role of 5-HT6 receptors in memory formation
A Meneses
DRUG NEWS & PERSPECTIVES (2001)
Cloning of the mouse 5-HT6 serotonin receptor and mutagenesis studies of the third cytoplasmic loop
R Kohen et al.
MOLECULAR BRAIN RESEARCH (2001)
Dimebon improves learning in animals with experimental Alzheimer's disease
NN Lermontova et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2000)
In vivo effects of the 5-HT6 antagonist SE-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate
LA Dawson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
分享论文
